Your browser doesn't support javascript.
loading
Evaluation of the Clinical and Microbiological Response to Salmonella Paratyphi A Infection in the First Paratyphoid Human Challenge Model.
Dobinson, Hazel C; Gibani, Malick M; Jones, Claire; Thomaides-Brears, Helena B; Voysey, Merryn; Darton, Thomas C; Waddington, Claire S; Campbell, Danielle; Milligan, Iain; Zhou, Liqing; Shrestha, Sonu; Kerridge, Simon A; Peters, Anna; Stevens, Zoe; Podda, Audino; Martin, Laura B; D'Alessio, Flavia; Thanh, Duy Pham; Basnyat, Buddha; Baker, Stephen; Angus, Brian; Levine, Myron M; Blohmke, Christoph J; Pollard, Andrew J.
Afiliação
  • Dobinson HC; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK.
  • Gibani MM; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK.
  • Jones C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK.
  • Thomaides-Brears HB; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK.
  • Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK.
  • Darton TC; Nuffield Department of Primary Care Health Sciences, University of Oxford, United Kingdom.
  • Waddington CS; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK.
  • Campbell D; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK.
  • Milligan I; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK.
  • Zhou L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK.
  • Shrestha S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK.
  • Kerridge SA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK.
  • Peters A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK.
  • Stevens Z; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK.
  • Podda A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK.
  • Martin LB; GSK Vaccines Institute for Global Health, Siena, Italy.
  • D'Alessio F; GSK Vaccines Institute for Global Health, Siena, Italy.
  • Thanh DP; European Vaccine Initiative, Heidelberg, Germany.
  • Basnyat B; Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
  • Baker S; Oxford University Clinical Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal.
  • Angus B; Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
  • Levine MM; Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.
  • Blohmke CJ; London School of Hygiene and Tropical Medicine, London, UK.
  • Pollard AJ; Nuffield Department of Medicine, University of Oxford, United Kingdom.
Clin Infect Dis ; 64(8): 1066-1073, 2017 04 15.
Article em En | MEDLINE | ID: mdl-28158395
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Salmonella paratyphi A / Bacteriemia / Febre Paratifoide Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Infect Dis Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Salmonella paratyphi A / Bacteriemia / Febre Paratifoide Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Infect Dis Ano de publicação: 2017 Tipo de documento: Article